 HANOVER, Md., Aug. 06, 2021 GLOBE NEWSWIRE -- Processa Pharmaceuticals, Inc. Nasdaq: PCSA, a clinical stage biopharmaceutical company developing products to improve the survival andor quality of life for patients who have an unmet medical need condition announces today it will host a conference call and live webcast on August 12, 2021, at 5:30 p.m. EST to discuss its second quarter 2021 results and provide an update on its clinical pipeline. 